There are times when it’s better to be lucky than good. Years ago and we do mean years ago we came across two Novo Nordisk executives celebrating at a bar. We asked what the celebration was all about they noted they had just signed a deal with JNJ. (Anyone remember the InDuo device.) Well thanks to my beautiful bride who kept asking question I knew this would be yet another Diabetic Investor scope, which it was. Imagine how these guys felt when the JNJ team joined them and informed them that they had just been talking with David Kliff . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.